The American Journal of Managed Care
This supplement to provides participants with currentinformation on oncology and how it affects managed care decision making, including coveragepolicy, reimbursement, and patient care. Jill Mullen, MPA, contributed to the writing ofDr McGivney's article. This supplement has been peer reviewed by an expert in the field.
Faculty
Guest Editor
William T. McGivney, PhD
Chief Executive Officer
National Comprehensive Cancer Network
Jenkintown, Pennsylvania
Guest Commentator
Lee N. Newcomer, MD
Oncology Services
UnitedHealth Group
Edina, Minnesota
Faculty Disclosure
In accordance with the ACCME, participants for this activity have completed conflict-of-intereststatements.
In compliance with the Health Insurance Portability and Accountability Act standards, no presentationsin this CME activity shall disclose the names or other identifiers of patients referencedwithout a signed waiver from the identified patient.
The American Journal of Managed Care
It is the policy of to have all faculty who participate inprograms sponsored by pharmaceutical organizations disclose any real or apparent conflictsof interest.
The following faculty member reports no relevant relationships with pharmaceutical companies:
Investigational and/or Off-label Use of Commercial Products and Devices
The University of Cincinnati College of Medicine requires all faculty to disclose any discussion ofinvestigational and/or off-label use of a pharmaceutical product or device within their presentation/report. Participants should note that the use of products outside US Food and DrugAdministration-approved labeling should be considered experimental and are advised to consultcurrent prescribing information for approved indications.
The faculty claim not to discuss any investigational and/or off-label use of a pharmaceutical productor device.
The American Journal of Managed Care,
Signed disclosures are on file at the offices of Jamesburg,New Jersey.